Exhibit 4.9


 


NEITHER THIS SECURITY NOR THE SECURITIES AS TO
WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH
SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.


 


COMMON SHARE PURCHASE WARRANT


 


1847 HOLDINGS LLC


 


Warrant Shares: 14,400


Date of Issuance: July 8, 2022 (“Issuance Date”)


 


This COMMON SHARE PURCHASE
WARRANT (the “Warrant”) certifies that, for services provided according to a Fee Agreement, dated June 19, 2022 (the
“Fee Agreement”), J.H. Darbie & Co., Inc., a New York corporation (including any permitted and registered assigns,
the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time during the Exercise Period (as defined below), to purchase from 1847 Holdings LLC, a Delaware limited liability
company (the “Company”), up to 14,400 Common Shares of the Company (the “Warrant Shares”) (whereby
such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then
in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement,
as of the date hereof, by and among the Company and the Introduced Party (as defined in the Fee Agreement).


 


Terms used in this Warrant
shall have the meanings set forth in Section 13 below. For purposes of this Warrant, the term “Exercise Price” shall
mean $1.875, subject to adjustment as provided herein (including but not limited to cashless exercise), and the term “Exercise
Period” shall mean the period commencing on the Issuance Date and ending on 5:00 p.m. eastern standard time on the date which
is five years after the Issuance Date.


 


1.
EXERCISE OF WARRANT.


 


(a)
Mechanics of Exercise. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised
in whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as Exhibit
A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. The Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant resulting in purchases of
a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. On or before the second Trading
Day (the “Warrant Share Delivery Date”) following the date on which the Holder sent the Exercise Notice to the Company
or the Company’s transfer agent, and upon receipt by the Company of payment to the Company of an amount equal to the applicable
Exercise Price multiplied by the number of Warrant Shares as to which all or a portion of this Warrant is being exercised (the “Aggregate
Exercise Price” and together with the Exercise Notice, the “Exercise Delivery Documents”) in cash or by wire
transfer of immediately available funds (or by cashless exercise, in which case there shall be no Aggregate Exercise Price provided),
the Company shall (or direct its transfer agent to) issue and deliver by overnight courier to the address as specified in the Exercise
Notice, a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Common
Shares to which the Holder is entitled pursuant to such exercise (or deliver such Common Shares in electronic format if requested by the
Holder). Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates
evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of Warrant Shares represented
by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise, then the Company
shall as soon as practicable and in no event later than three Trading Days after any exercise and at its own expense, issue a new Warrant
(in accordance with Section 6) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise
under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised.


 


If the Company fails to cause
its transfer agent to issue to the Holder the respective Common Shares by the respective Warrant Share Delivery Date, then the Holder
will have the right to rescind such exercise in Holder’s sole discretion in addition to all other rights and remedies at law, under
this Warrant, or otherwise, and such failure shall also be deemed a material breach under this Warrant.


 



     


     


    

 


If the Market Price of one
Common Share is greater than the Exercise Price, then the Holder may elect to receive Warrant Shares pursuant to a cashless exercise,
in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below (or of any portion thereof remaining
unexercised) by surrender of this Warrant and an Exercise Notice, in which event the Company shall issue to Holder a number of Common
Shares computed using the following formula:


 


X = Y (A-B)


A


 


Where X =the number of
Warrant Shares to be issued to Holder.


 


 Y = the number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date of such calculation).




 


A = the
Market Price (at the date of such calculation).


 


B = Exercise
Price (as adjusted to the date of such calculation).


 


(b)
No Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment
pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining
whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance
of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction
a sum in cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.


 


(c)
Holder’s Exercise Limitations. Notwithstanding anything to the contrary contained herein, the Company shall not effect
any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 1 or
otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Exercise Notice, the
Holder (together with the Holder’s affiliates (the “Affiliates”), and any other Persons acting as a group together
with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of Common
Shares beneficially owned by the Holder and Attribution Parties shall include the number of Common Shares issuable upon exercise of this
Warrant with respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or
Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company
(including, without limitation, any other Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the
preceding sentence, for purposes of this Section 1(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Holder is solely responsible for any schedules required to be filed in accordance therewith.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 1(c), in determining the number of outstanding
Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company’s most recent periodic
or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
written notice by the Company or the Company’s transfer agent setting forth the number of Common Shares outstanding. Upon the written
or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of Common
Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding Common Shares was reported. The “Beneficial Ownership Limitation” shall be 4.99%
of the number of Common Shares outstanding at the time of the respective calculation hereunder. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.


 


2.
ADJUSTMENTS. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:


 


(a)
Anti-Dilution Adjustments to Exercise Price. If the Company or any subsidiary thereof, as applicable, at any time while
this Warrant is outstanding, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of
or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Shares or securities (including
but not limited to Common Share Equivalents) entitling any Person to acquire Common Shares (upon conversion, exercise or otherwise), at
an effective price per share less than the then Exercise Price (such lower price, the “Base Share Price” and such issuances
collectively, a “Dilutive Issuance”) (if the holder of the Common Shares or Common Share Equivalents so issued shall
at any time, whether by operation of purchase price adjustments, elimination of an applicable floor price for any reason in the future
(including but not limited to the passage of time or satisfaction of certain condition(s)), reset provisions, floating conversion, exercise
or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be
entitled or potentially entitled to receive Common Shares at an effective price per share which is less than the Exercise Price at any
time while such Common Shares or Common Share Equivalents are in existence, such issuance shall be deemed to have occurred for less than
the Exercise Price on such date of the Dilutive Issuance (regardless of whether the Common Shares or Common Share Equivalents are (i)
subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted or exercised at such
Base Share Price), then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal the Base Share Price.
Such adjustment shall be made whenever such Common Shares or Common Share Equivalents are issued, regardless of whether the Common Shares
or Common Share Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually
converted or exercised at such Base Share Price by the holder thereof (for the avoidance of doubt, the Holder may utilize the Base Share
Price even if the Company did not actually issue Common Shares at the Base Share Price under the respective Common Share Equivalents).
The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common Shares or Common Share
Equivalents subject to this Section 2(a), indicating therein the applicable issuance price, or applicable reset price, exchange price,
conversion price and other pricing terms (such notice the “Dilutive Issuance Notice”). For purposes of clarification,
regardless of whether (i) the Company provides a Dilutive Issuance Notice pursuant to this Section 2(a) upon the occurrence of any Dilutive
Issuance or (ii) the Holder accurately refers to the Base Share Price in the Exercise Notice, the Holder is entitled to receive the Base
Share Price at all times on and after the date of such Dilutive Issuance. Notwithstanding the foregoing, this Section 2(a) shall not apply
to the Excluded Transactions.


 






    2


     


    

 


(b)
Subdivision or Combination of Common Shares. If the Company at any time on or after the Issuance Date subdivides (by any
share split, share dividend, recapitalization or otherwise) one or more classes of its outstanding Common Shares into a greater number
of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant
Shares will be proportionately increased. If the Company at any time on or after the Issuance Date combines (by combination, reverse share
split or otherwise) one or more classes of its outstanding Common Shares into a smaller number of shares, the Exercise Price in effect
immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased.
Any adjustment under this Section 2(b) shall become effective at the close of business on the date the subdivision or combination becomes
effective. Each such adjustment of the Exercise Price shall be calculated to the nearest one-hundredth of a cent. Such adjustment shall
be made successively whenever any event covered by this Section 2(b) shall occur.


 


3.
FUNDAMENTAL TRANSACTIONS. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company
with or into another entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”),
(ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant
to which holders of Common Shares are permitted to tender or exchange their Common Shares for other securities, cash or property and the
holders of at least 50% of the Common Shares accept such offer, or (iv) the Company effects any reclassification of the Common Shares
or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of Common Shares) (in any such case, a “Fundamental
Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive the number of
Common Shares of the Successor Entity or of the Company and any additional consideration (the “Alternate Consideration”)
receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of
the number of Common Shares for which this Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise
contained herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the Exercise Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental Transaction shall issue to the
Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise such warrant into Alternate
Consideration.


 


4.
NON-CIRCUMVENTION. The Company covenants and agrees that it will not, by amendment of its certificate of formation, operating
agreement or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale
of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the
rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any Common
Shares receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Common Shares upon the
exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved, free from preemptive
rights, one and a half (1.5) times the number of Common Shares into which the Warrants are then exercisable into to provide for the exercise
of the rights represented by this Warrant (without regard to any limitations on exercise).


 


5.
WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, this Warrant, in and of itself,
shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company. In addition, nothing contained in this
Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.


 


6.
REISSUANCE.


 


(a)
Lost, Stolen or Mutilated Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms
as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.


 


(b)
Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant,
such new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant
which is the same as the Issuance Date.


 






    3


     


    

 


7.
TRANSFER. This Warrant shall be binding upon the Company and its successors and assigns and shall inure to be the benefit
of the Holder and its successors and assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations of
the Company hereunder may not be assigned, by operation of law or otherwise, in whole or in part, by the Company without the prior signed
written consent of the Holder, which consent may be withheld at the sole discretion of the Holder (any such assignment or transfer shall
be null and void if the Company does not obtain the prior signed written consent of the Holder). This Warrant or any of the severable
rights and obligations inuring to the benefit of or to be performed by Holder hereunder may be assigned by Holder to a third party, in
whole or in part, without the need to obtain the Company’s consent thereto.


 


8.
NOTICES. The Company shall provide the Holder with prompt written notice (i) immediately upon any adjustment of the Exercise
Price, setting forth in reasonable detail, the calculation of such adjustment and (ii) at least 20 days prior to the date on which the
Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Shares, (B) with respect to
any grants, issuances or sales of any stock or other securities directly or indirectly convertible into or exercisable or exchangeable
for Common Shares or other property, pro rata to the holders of Common Shares or (C) for determining rights to vote with respect to any
Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public prior
to or in conjunction with such notice being provided to the Holder. All notices, demands, requests, consents, approvals, and other communications
required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be personally served, deposited in the
mail, registered or certified, return receipt requested, postage prepaid, delivered by reputable air courier service with charges prepaid,
or transmitted by hand delivery, telegram, e-mail or facsimile, addressed as set forth below or to such other address as such party shall
have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be
deemed effective (i) upon hand delivery or delivery by e-mail or facsimile, with accurate confirmation generated by the transmitting facsimile
machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to
be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours
where such notice is to be received) or (ii) on the second business day following the date of mailing by express courier service, fully
prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications
shall be:


 


If to the Company, to:


 


1847 Holdings
LLC


590 Madison
Avenue, 21st Floor


New York,
NY 10022


Attention:
Ellery Roberts


e-mail:
info@1847holdings.com


 


If to the Holder:


 


J.H. Darbie
& Co., Inc.


48 Wall
Street, Suite 1206 


New York,
NY 10005


e-mail:



 


9.
AMENDMENT AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance and
either retroactively or prospectively) only with the written consent of the Company and the Holder.


 


10.
GOVERNING LAW AND VENUE. This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware
without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Warrant shall be brought only in the state courts located in the Commonwealth of Massachusetts or federal courts located in the
Commonwealth of Massachusetts. The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY
DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT ENTERED INTO IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION
CONTEMPLATED HEREBY OR THEREBY. The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees
and costs. In the event that any provision of this Warrant or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith
and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable
under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives
personal service of process and consents to process being served in any suit, action or proceeding in connection with this Warrant or
any other transaction document entered into in connection with this Warrant by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under Section 8 and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any other manner permitted by law.


 






    4


     


    

 


11.
PIGGYBACK REGISTRATION RIGHTS.


 


(a)
If at any time the Company proposes to file any registration statement (a “Registration Statement”) under the
Securities Act of 1933, as amended (the “Securities Act”), with respect to any offering of equity securities, or securities
or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Company for its own account or for
shareholders of the Company for their account (or by the Company and by shareholders of the Company), other than a Registration Statement
(i) filed in connection with any employee stock option or other benefit plan on Form S-8, (ii) for a dividend reinvestment plan or (iii)
in connection with a merger or acquisition, then the Company shall (x) give written notice of such proposed filing to the Holder as soon
as practicable but in no event less than ten (10) days before the anticipated filing date of the Registration Statement, which notice
shall describe the amount and type of securities to be included in such Registration Statement, the intended method(s) of distribution,
and the name of the proposed managing underwriter or underwriters, if any, of the offering, and (y) offer to the Holder in such notice
the opportunity to register the sale of such number of Warrant Shares (the “Registrable Securities”) as the Holder
may request in writing within three (3) days following receipt of such notice (a “Piggy-Back Registration”). The Company
shall cause such Registrable Securities to be included in such registration and shall cause the managing underwriter or underwriters of
a proposed underwritten offering to permit the Registrable Securities requested to be included in a Piggy-Back Registration on the same
terms and conditions as any similar securities of the Company and to permit the sale or other disposition of such Registrable Securities
in accordance with the intended method(s) of distribution thereof. The Holder proposing to distribute its securities through a Piggy-Back
Registration that involves an underwriter or underwriters shall enter into an underwriting agreement in customary form with the underwriter
or underwriters selected for such Piggy-Back Registration.


 


(b)
The Holder may elect to withdraw its request for inclusion of Registrable Securities in any Piggy-Back Registration by giving written
notice to the Company of such request to withdraw prior to the effectiveness of the Registration Statement. The Company (whether on its
own determination or as the result of a withdrawal by persons making a demand pursuant to written contractual obligations) may withdraw
a Registration Statement at any time prior to the effectiveness of such Registration Statement. Notwithstanding any such withdrawal, the
Company shall pay all expenses incurred by the Holder in connection with such Piggy-Back Registration as provided in Section 11(e) below.


 


(c)
The Company shall notify the Holder at any time when a prospectus relating to the Holder’s Registrable Securities is required
to be delivered under the Securities Act, upon discovery that, or upon the happening of any event as a result of which, the prospectus
included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state any material
fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing.
At the request of the Holder, the Company shall also prepare, file and furnish to the Holder a reasonable number of copies of a supplement
to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of the Registrable Securities,
such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading in light of the circumstances then existing. The Holder shall not to offer
or sell any Registrable Securities covered by the Registration Statement after receipt of such notification until the receipt of such
supplement or amendment.


 


(d)
The Company may request that the Holder furnish the Company such information with respect to the Holder and its proposed distribution
of the Registrable Securities pursuant to the Registration Statement as the Company may from time to time reasonably request in writing
or as shall be required by law or by the Securities and Exchange Commission (the “SEC”) in connection therewith, and
the Holder shall furnish the Company with such information.


 


(e)
All fees and expenses incident to the performance of or compliance with this Section 11 by the Company shall be borne by the Company
whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing
sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of
the Company’s counsel and independent registered public accountants) (A) with respect to filings made with the SEC, (B) with respect
to filings required to be made with any trading market on which the Common Shares are then listed for trading, (C) in compliance with
applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements
of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities) and (D) with respect
to any filing that may be required to be made by any broker through which a holder of Registrable Securities intends to make sales of
Registrable Securities with the FINRA, (ii) printing expenses, (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements
of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, (vi) fees and expenses of
all other persons or entities retained by the Company in connection with the consummation of the transactions contemplated by this Section
11 and (vii) reasonable fees and disbursements of a single special counsel for the Holder. In addition, the Company shall be responsible
for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Section 11 (including,
without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any
annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange
as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of the Holder.


 






    5


     


    

 


(f) The
Company and its successors and assigns shall indemnify and hold harmless the Holder, the officers, directors, members, partners,
agents and employees (and any other individuals or entities with a functionally equivalent role of a person holding such titles,
notwithstanding a lack of such title or any other title) of each of the Holder, each individual or entity who controls the Holder
(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members,
stockholders, partners, agents and employees (and any other individuals or entities with a functionally equivalent role of a person
holding such titles, notwithstanding a lack of such title or any other title) of each such controlling individual or entity (each,
an “Indemnified Party”), to the fullest extent permitted by applicable law, from and against any and all losses,
claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively,
“Losses”), as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material
fact contained in a Registration Statement, any related prospectus or any form of prospectus or in any amendment or supplement
thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact
required to be stated therein or necessary to make the statements therein (in the case of any such prospectus or supplement thereto,
in light of the circumstances under which they were made) not misleading or (ii) any violation or alleged violation by the Company
of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the
performance of its obligations under this Section 11, except to the extent, but only to the extent, that such untrue statements or
omissions are based upon information regarding the Holder furnished to the Company by the Holder for use therein. The Company shall
notify the Holder promptly of the institution, threat or assertion of any proceeding arising from or in connection with the
transactions contemplated by this Section 11 of which the Company is aware.


 


(g)
If the indemnification under Section 11(f) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then the Company shall contribute to the amount paid or payable by such Indemnified Party, in such proportion
as is appropriate to reflect the relative fault of the Company and Indemnified Party in connection with the actions, statements or omissions
that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of the Company and Indemnified
Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information
supplied by, the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed
to include any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any proceeding to the extent
such party would have been indemnified for such fees or expenses if the indemnification provided for in Section 11(f) was available to
such party in accordance with its terms. It is agreed that it would not be just and equitable if contribution pursuant to this Section
11(f) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations
referred to in the immediately preceding sentence. Notwithstanding the provisions of this Section 11(g), the Holder shall not be required
to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such party from the
sale of all Registrable Securities pursuant to such Registration Statement or related prospectus exceeds the amount of any damages that
the Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.


 


12.
ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained herein.


 


13.
CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:


 


(a)
“Common Shares” means the Company’s Common Shares, and any other class of securities into which such securities
may hereafter be reclassified or changed.


 


(b)
“Common Share Equivalents” means any securities of the Company that would entitle the holder thereof to acquire
at any time Common Shares, including without limitation any debt, preferred shares, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares.


 






    6


     


    

 


(c)
“Excluded Transactions” means transactions involving the issuance of the following securities of the Company:
(i) the Common Shares to be sold in the Company’s contemplated public offering (Registration Statement No. 333-259011 (the “Public
Offering Registration Statement”)), as well as the warrants issuable to the underwriters in connection therewith (including
the Common Shares issuable upon the exercise of such warrants), (ii) the issuance by the Company of Common Shares upon the exercise of
an outstanding option or warrant or the conversion of a security outstanding on the date hereof, (iii) any issuance of securities disclosed
in the Public Offering Registration Statement, (iv) an offering of up to $50 million of senior convertible preferred shares in a private
placement offering, and the underlying Common Shares issuable upon conversion of such securities, (v) the issuance of securities issued
as part of the purchase price in connection with acquisitions or strategic transactions approved a majority of the disinterested directors
of the Company, or securities issued in financing transactions, the primary purpose of which is to finance acquisitions or strategic transactions
approved a majority of the disinterested directors of the Company, (vi) Common Shares, options or convertible securities issued to banks,
equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real
property leasing transaction, approved by a majority of the disinterested directors of the Company, but shall not include a transaction
in which the Company is primarily issuing such securities primarily for the purpose of raising capital or to a person or an entity whose
primary business is investing in securities, (vii) Common Shares, options or convertible securities issued to in connection with the provision
of goods or services pursuant to transactions approved by a majority of the disinterested directors of the Company, but shall not include
a transaction in which the Company is primarily issuing such securities primarily for the purpose of raising capital or to a person or
an entity whose primary business is investing in securities, (viii) Common Shares, options or convertible securities issued in connection
with sponsored research, collaboration, technology license, development, investor or public relations, marketing or other similar agreements
or strategic partnerships approved a majority of the disinterested directors of the Company, but shall not include a transaction in which
the Company is primarily issuing such securities primarily for the purpose of raising capital or to a person or an entity whose primary
business is investing in securities, (ix) the issuance by the Company of any Common Shares or standard options to purchase Common Shares
to directors, officers, employees or consultants of the Company or its subsidiaries in their capacity as such pursuant to an equity incentive
plan approved by a majority of the disinterested directors of the Company, or (x) the issuance of securities pursuant to any other arrangements
that are in place or disclosed in the Company’s filings with the SEC prior to the date of this Warrant.


 


(d)
“Person” and “Persons” means an individual, a limited liability company, a partnership, a joint
venture, a corporation, a trust, an unincorporated organization, any other entity and any governmental entity or any department or agency
thereof.


 


(e)
“Principal Market” means the principal securities exchange or trading market where such Common Shares are listed
or quoted, including but not limited to any tier of the OTC Markets, any tier of the NASDAQ Stock Market (including the NASDAQ Capital
Market), the New York Stock Exchange or the NYSE American, or any successor to such markets.


 


(f) “Market
Price” means the highest traded price of the Common Shares during the one hundred and fifty Trading Days prior to the date
of the respective Exercise Notice.


 


(g)
“Trading Day” means any day on which the Common Shares are listed or quoted on its Principal Market, provided,
however, that if the Common Shares are not then listed or quoted on any Principal Market, then any calendar day.


 


* * * * * * *


 






    7


     


    

 


IN WITNESS WHEREOF, the Company
has caused this Warrant to be duly executed as of the Issuance Date set forth above. 


 


	 	1847 Holdings LLC
	 	 
	 	By: 	/s/ Ellery W. Roberts
	 	Name: 	Ellery W. Roberts
	 	Title: 	Chief Executive Officer



 






    8


     


    

 





EXHIBIT A


 


EXERCISE NOTICE


 


(To be executed
by the registered holder to exercise this Common Share Purchase Warrant)


 


 


THE UNDERSIGNED holder hereby
exercises the right to purchase __________ Common Shares (“Warrant Shares”) of 1847 HOLDINGS LLC, a Delaware limited liability
company (the “Company”), evidenced by the attached copy of the Common Share Purchase Warrant (the “Warrant”).
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.


 


		1.	Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as (check one):



 


		☐	a cash exercise with respect to ___________Warrant Shares; or



 


		☐	by cashless exercise pursuant to the Warrant.



 


		2.	Payment of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable
Aggregate Exercise Price in the sum of $______________ to the Company in accordance with the terms of the Warrant.



 


		3.	Delivery of Warrant Shares. The Company shall deliver to the holder ____________Warrant Shares
in accordance with the terms of the Warrant.



 


 


	Date: 	               	 


 


	 	 
	 	(Print Name of Registered Holder)
	 	 
	 	By:	                 
	 	Name:	 
	 	Title:	 


 






     


     


    

 





EXHIBIT B


 


ASSIGNMENT OF WARRANT


 


(To be signed only upon authorized
transfer of the Warrant)


 


FOR VALUE RECEIVED, the
undersigned hereby sells, assigns, and transfers unto _________________________________________________________________________ the right
to purchase ______________________________ Common Shares of 1847 HOLDINGS LLC to which the within Common Share Purchase Warrant relates
and appoints _________________________, as attorney-in-fact, to transfer said right on the books of 1847 HOLDINGS LLC with full power
of substitution and re-substitution in the premises. By accepting such transfer, the transferee has agreed to be bound in all respects
by the terms and conditions of the within Warrant.


 


	Dated: 	               	 



 


	 	 
	 	(Signature) *
	 	 
	 	 
	 	(Name)
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Social Security or Tax Identification No.)



 


		*	The signature on this Assignment of Warrant must correspond
to the name as written upon the face of the Common Share Purchase Warrant in every particular without alteration or enlargement or any
change whatsoever. When signing on behalf of a corporation, partnership, trust or other entity, please indicate your position(s) and
title(s) with such entity.